一个家族性孤立性甲状旁腺功能减退症家系中的常染色体显性PTH基因信号序列突变
本文报告一个三代家族性孤立性甲状旁腺功能减退症(FIH)家系,6名成员中3例患者表现为严重低钙血症和血清PTH不适当降低。基因分析未发现CASR、GCM2、GNA11突变,检出PTH基因外显子2杂合变异(c.41T>A;p.M14K)并与疾病共分离;体外实验显示M14K突变体细胞内滞留增加、分泌受损,4-苯基丁酸可减少滞留并增加培养基中蓄积。
要点
- FIH家系中检出PTH基因信号序列杂合错义变异c.41T>A(p.M14K),与疾病共分离。
- HEK293细胞实验显示M14K突变体细胞内滞留增加、分泌受损。
- 4-苯基丁酸可减少M14K突变体细胞内滞留并增加其在培养基中蓄积。
核心结论
- 本文报告一个FIH家系中的PTH基因杂合突变,并证明突变体在细胞内蓄积且分泌受损。
- 对此类甲状旁腺功能减退症患者进行准确的基因诊断对适当治疗和遗传咨询至关重要。
研究设计与样本
- 对三代FIH家系6名成员(其中3例患者有严重低钙血症和血清PTH不适当降低)进行CASR、GCM2、GNA11和PTH基因突变分析。
- 对检出的变异进行功能测定,包括HEK293细胞实验和4-苯基丁酸干预。
主要发现
- CASR、GCM2和GNA11基因未检出突变。
- 检出PTH基因外显子2杂合变异c.41T>A(p.M14K),与疾病共分离。
- 该错义变异位于信号序列疏水核心,计算机预测其损害前甲状旁腺激素原(preproPTH)向甲状旁腺激素原(proPTH)的切割。
- HEK293细胞功能测定显示,与野生型相比,M14K突变体细胞内滞留大幅增加而分泌至培养基受损。
- 加入药理学伴侣4-苯基丁酸后,M14K突变体细胞内滞留减少、培养基中蓄积增加。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Familial isolated hypoparathyroidism (FIH) is a genetically heterogeneous disorder due to mutations of the calcium-sensing receptor (CASR), glial cells missing-2 (GCM2), guanine nucleotide binding protein α11 (GNA11), or parathyroid hormone (PTH) genes. Thus far, only four cases with homozygous and two cases with heterozygous mutations in the PTH gene have been reported. OBJECTIVE: To clinically describe an FIH family and identify and characterize the causal gene mutation. DESIGN: Genomic DNA of the family members was subjected to CASR, GCM2, GNA11, and PTH gene mutational analysis. Functional assays were performed on the variant identified. PARTICIPANTS: Six subjects of a three-generation FIH family with three affected individuals having severe hypocalcemia and inappropriately low serum PTH. RESULTS: No mutations were detected in the CASR, GCM2, and GNA11 genes. A heterozygous variant that segregated with the disease was identified in PTH gene exon 2 (c.41T>A; p.M14K). This missense variant, in the hydrophobic core of the signal sequence, was predicted in silico to impair cleavage of preproPTH to proPTH. Functional assays in HEK293 cells demonstrated much greater retention intracellularly but impaired secretion into the medium of the M14K mutant relative to wild type. The addition of the pharmacological chaperone, 4-phenylbutyric acid, led to a reduction of cellular retention and increased accumulation in the cell medium of the M14K mutant. CONCLUSIONS: We report a heterozygous PTH mutation in an FIH family and demonstrate accumulation of the mutant intracellularly and its impaired secretion. An accurate genetic diagnosis in such hypoparathyroid patients is critical for appropriate treatment and genetic counseling.
引用
- Cinque L, Sparaneo A, Penta L, et al. Autosomal Dominant PTH Gene Signal Sequence Mutation in a Family With Familial Isolated Hypoparathyroidism. J Clin Endocrinol Metab. 2017. PMID: 28938448. doi:10.1210/jc.2017-00250
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。